We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
AMES, Iowa – Drug-delivering nanoparticles could improve treatments for inflammatory bowel diseases that affect the quality of life of more than 3 million Americans, Iowa State University researchers say.
